AbbVie Submits for EU Marketing Authorization its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Chronic Hepatitis C

[PR Newswire] – NORTH CHICAGO, Ill., May 8, 2014 /PRNewswire/ — AbbVie (ABBV) submitted marketing authorization applications (MAAs) to the European Medicines Agency (EMA) seeking approval for the company’s investigational, all-oral, interferon-free regi more

View todays social media effects on ENTA

View the latest stocks trending across Twitter. Click to view dashboard

See who Enanta is hiring next, click here to view